首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 60 毫秒
1.
破壁松花粉及软胶囊抗前列腺增生作用   总被引:1,自引:0,他引:1  
目的 观察破壁松花粉(SHF)及软胶囊(PPCM)的抗前列腺增生(BPH)作用.方法 大鼠皮下注射丙酸睾酮3周造成前列腺增生模型,破壁松花粉及软胶囊灌胃给药4周,测定血清酸性磷酸酶活性;测定前列腺重量和体积,以及精囊腺、睾丸、附睾、提肛肌、膀胱湿重,计算脏器指数;测定前列腺组织DNA及蛋白含量.结果 与模型组比较,SHF对大鼠前列腺重量和体积及膀胱指数有明显抑制,但PpCM对大鼠前列腺体积无明显抑制;而二者对精囊腺、睾丸、附睾、提肛肌等脏器指数的抑制均无明显差异,对血清酸性磷酸酶(ACP)、前列腺组织的DNA和蛋白含量也无明显影响.结论 破壁松花粉及软胶囊具有抗大鼠BPH的作用.  相似文献   

2.
目的:研究亚麻籽木脂素(SDG)对丙酸睾酮诱导的大鼠前列腺增生的抑制作用,并阐明其作用机制.方法:50只雄性Wistar大鼠随机分为空白组、模型组、阳性药(非那雄胺1.0 mg·kg-1)组及SDG(1.2和0.4 g·kg-1)组.ELISA方法检测前列腺组织中一氧化氮(NO)、超氧化物歧化酶(SOD)、过氧化氢酶(...  相似文献   

3.
非那雄胺与多沙唑嗪联用对鼠前列腺增生模型的影响   总被引:1,自引:0,他引:1  
目的:探讨非那雄胺与多沙唑嗪联用对鼠前列腺增生模型的影响。方法:将34只雄性W istar大鼠,随机分为模型组(28只)、假手术组(6只)。造模成功后将24只模型鼠随机分为非那雄胺与多沙唑嗪联用、非那雄胺、多沙唑嗪组、阴性对照组,继续予皮下注射丙酸睾酮4mg/d.kg造模,连续4周;假手术组继续予皮下注射等量橄榄油4周。各组实验鼠分别于注射4周后处死,取出前列腺,光镜下观察其形态学变化,计算各实验组前列腺指数(PI)。免疫组化检测bax、fas、bcl-2蛋白表达情况。结果:与阴性对照组相比,给药4周后非那雄胺与多沙唑嗪联用、非那雄胺组PI、bcl-2表达下降(P<0.05),bax、fas表达增加(P<0.05)。结论:两种药物联用显著地降低了鼠前列腺增生的进展,有望成为临床治疗前列腺增生的新方法。  相似文献   

4.
目的:观察前列消汤治疗前列腺增生的疗效并初步探讨其作用机理。方法:采用丙酸睾酮致大鼠前列腺增生模型,进行随机对照分组研究,观察给药前后大鼠前列腺体积、前列腺指数、血清前列腺特异抗原(PSA)及性激素变化。结果:前列消汤可以明显抑制模型大鼠的前列腺增生,减小大鼠前列腺体积、湿重、前列腺指数,降低大鼠的睾酮(T)水平,提高大鼠的雌二醇(E2)、E2/T水平,降低大鼠血清PSA的表达。结论:前列消汤对丙酸睾酮所致前列腺增生有明显的抑制和治疗作用,其机制可能是通过调整体内性激素水平和比例,抑制前列腺细胞增殖;同时减低前列腺组织淤血,减少腺腔分泌物来实现的。  相似文献   

5.
紫花茉莉抗实验性前列腺增生的作用观察   总被引:2,自引:0,他引:2  
[目的]观察紫花茉莉抗实验性前列腺增生的作用。[方法]NIH小鼠60只,随机分为空白对照组、模型组、保列治组(1 mg·kg-1·d-1)和紫花茉莉组(150 g·kg-1·d-1);除空白对照组外,其他小鼠均采用皮下注射丙酸睾丸素(5mg·kg-1 ·d-1,共21 d)方法复制前列腺增生模型,造模结束后各给药组按设计剂量给药,空白对照组和模型组给予等容积生理盐水,连续30d;分别测定各组前列腺湿质量,采用放射免疫分析法检测各组小鼠血清睾酮(T)、双氢睾酮(DHT)含量。[结果]模型组前列腺湿质量,血清T、DHT含量均升高,与空白对照组比较具有显著性差异(均P<0.01);紫花茉莉组和保列治组均可降低前列腺湿质量,血清T、DHT含量,与模型组比较具有统计学差异(均P<0.01),而2组间比较无显著性差异。[结论]紫花茉莉治疗前列腺增生的作用可能与其抑制睾酮转化为双氢睾酮有关。  相似文献   

6.
目的探讨益肾通癃胶囊对前列腺增生(benign prostatic hyperplasia,BPH)模型大鼠雌雄激素比及缺氧诱导因子1α(chypoxia-inducible fac tor-1α,HIF-1α)的影响。方法对SD雄性大鼠皮下注射丙酸睾酮5 mg/(kg·d),连续4周。造模成功后将大鼠随机分为4组:正常组、模型组、中药对照组和实验组,每组7只。实验组大鼠灌服0.365 g/kg益肾通癃胶囊混悬液;中药对照组灌服0.183 g/kg癃闭舒胶囊混悬液;正常组及模型组给予同等容量的生理盐水灌胃,连续灌胃8周后,光镜下观察前列腺组织病理学变化;称取前列腺湿重并计算前列腺指数;检测大鼠血清E2、T、DHT水平及E2/T;测定前列腺组织中HIF-1α蛋白表达。结果与模型组比较,实验组大鼠前列腺腺体轻微增生,少数呈乳头状增生,腺腔基本恢复正常。与模型组比较,实验组大鼠前列腺体积、前列腺湿重、前列腺指数及前列腺组织中的HIF-1α蛋白表达水平均降低(P<0.01);大鼠血清中的DHT、E2、T水平降低,E2/T比值升高(P<0.01)。结论益肾通癃胶囊可能通过降低BPH模型大鼠血清中的DHT、E2、T水平,升高E2/T比值,抑制HIF-1α的表达起治疗BPH的作用。  相似文献   

7.
前列冲剂对大鼠前列腺增生影响的实验研究   总被引:1,自引:0,他引:1  
目的:观察前列冲剂对去势大鼠前列腺增生的影响。方法:将32只雄性昆明大鼠随机分为4个组,除对照组外,实验组大鼠均做去势手术,7d后实验组1皮下注射生理盐水,每天二次;实验组2皮下注射丙酸睾丸酮(4ml/kg),同时用生理盐水灌胃,每天两次;实验组3皮下注射丙酸睾丸酮(4ml/kg),同时用前列冲剂灌胃(5ml/kg),每天两次.5周后将大鼠处死,取出前列腺用10%福尔马林固定,常规HE染色,光镜观察。结果与正常对照组比较,实验组3大鼠前列腺组织有明显萎缩,而且主要表现为间质萎缩。结论:前列冲剂对良性前列腺组织增生有抑制作用.  相似文献   

8.
本试验研究了丙酸睾酮诱发的大鼠前列腺增生以及西咪(口替)丁的抗雄活性对这种增生的影响。结果表明,给予丙酸睾酮后的大鼠血浆睾丸酮(T)、双氢睾酮(DHT)和雌二醇(E_2)同时明显升高,前列腺、精囊、睾丸重量显著增加;西咪(口替)丁可明显抑制大鼠前列腺增生和精囊、睾丸的增重,降低血浆 T、DHT 和E_2的浓度,具有较强的抗雄抗雌活性。作者还测定了药物对大鼠前列腺腹叶中核酸含量的影响;讨论了 T、DHT 和 E_2在良性前列腺增生(BPH)发病中的作用;鉴于西咪(口替)丁具有抗雄抗雌活性和毒副作用少、价廉易得等优点,作者认为该药可临床应用治疗 BPH。  相似文献   

9.
前列腺增生大鼠模型的建立   总被引:1,自引:0,他引:1  
目的:探讨丙酸睾酮对去势和不去势SD大鼠前列腺增生的影响.方法:8周龄雄性SD大鼠25只,随机分为正常对照组(n=5)、不去势模型组(n=15)及去势模型组(n=5);不去势模型组按注射丙酸睾酮剂量又分为不去势低剂量组、中剂量组和高剂量组,注射剂量分别为1.25,2.5,5 mg/(kg·d);去势模型组无菌切除双侧睾丸1周后注射丙酸睾酮5 mg/(kg·d);去势模型组和不去势模型组均连续注射丙酸睾酮4周,于末次给药后分离大鼠前列腺,检测其湿重、体积和脏器系数;组织切片HE染色,光镜下观察前列腺组织变化.结果:不去势小剂量组和中剂量组的前列腺湿重、体积和脏器系数增加,与正常对照组相比差异有统计学意义(P<0.05),不去势高剂量组和去势组的前列腺体积和脏器系数与正常对照组相比,差异均具有统计学意义(P<0.01);去势组和不去势组大鼠前列腺体积和腺腔大小均较正常对照组增大,且不去势组前列腺腺体与周围组织界限更清楚,腺腔内乳头状突起也比去势组更加明显.结论:使用不去势、皮下注射5 mg/(kg·d)丙酸睾酮的方法可有效的建立前列腺增生大鼠模型.  相似文献   

10.
目的 :探讨淫羊藿苷对丙酸睾酮诱导的大鼠前列腺增生组织的影响。方法 :通过注射丙酸睾酮建立SD大鼠前列腺增生模型,分为空白组,模型对照组,非那雄胺组,淫羊藿苷高、中、低剂量组。完成给药后摘取前列腺组织分别比较前列腺湿重、体积变化,计算前列腺指数(PI)并观察前列腺组织变化,比较各组自噬蛋白LC-3、Beclin-1的表达。结果 :与模型对照组比较,淫羊藿苷对增生前列腺有明显抑制作用(P0.01或P0.05),高、中剂量效果更显著。结论 :淫羊藿苷对增生前列腺组织有明显抑制作用,并与剂量水平成正相关,且这种抑制作用可能与下调前列腺增生组织中相关蛋白(如LC-3和Beclin-1)、抑制过度自噬有关。  相似文献   

11.
FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…  相似文献   

12.
Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.  相似文献   

13.
In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.  相似文献   

14.
Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.  相似文献   

15.
16.
目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P<0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P<0.05),PaCO2均随观察时间的延长而降低(P<0.05).观察组治疗有效率为87.5%,显著高于对照组的70.0% (P <0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P<0.05),且观察组明显低于对照组(P<0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.  相似文献   

17.
Evidence obtained from randomized controlled trials (RCTs) has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine (TCM) and results have shown that there is an urgent need for higher quality RCTs on TCM.  相似文献   

18.
Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.  相似文献   

19.
20.
CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号